Aims (new version):

Aims (old version):

Biomedicines (ISSN 2227-9059) is an open access journal devoted to all aspects of research on human health and disease, the discovery and characterization of new therapeutic targets, therapeutic strategies, and research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. Topics include pathogenesis mechanisms of diseases, translational medical research, clinical studies and applications, biomaterial in biomedical research, natural bioactive molecules, biologics, biosimilar, vaccines, gene therapies, cell-based therapies, targeted specific antibodies, recombinant therapeutic proteins, nanobiotechnology-driven products, targeted therapy, bioimaging, biosensors, biomarkers, biosimilars, and nano-biosimilars.

We encourage authors to publish their experimental, theoretical, and computational results in as much detail as possible. There is no restriction on the maximum length of papers or the number of electronic multimedia and supplementary files. For all articles, the full experimental details must be provided so that the results can be reproduced. Electronic files regarding the full details of the experimental procedure, if unable to be published in a normal way, can be deposited as Supplementary Materials (including animated pictures, videos, interactive Excel sheets, software executables and others).

Biomedicines (ISSN 2227-9059) is an open access journal devoted to all aspects of research on human health and disease, the discovery and characterization of new therapeutic targets, therapeutic strategies, and research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. Topics include pathogenesis mechanisms of diseases, translational medical research, biomaterial in biomedical research, natural bioactive molecules, biologics, biosimilar, vaccines, gene therapies, cell-based therapies, targeted specific antibodies, recombinant therapeutic proteins, nanobiotechnology driven products, targeted therapy, bioimaging, biosensors, biomarkers, biosimilars, and nano-biosimilars. The journal is open for publication of studies conducted at the basic science and preclinical research levels. We invite you to consider submitting your work to Biomedicines, be it original research, review articles, or developing Special Issues of current key topics.

Biomedicines publishes high-quality papers that address the challenges in bringing biological agents or novel targeted strategies through identification, development, and, ultimately, to clinical use. Therefore, laboratory medicine research, translation medicinal research, and comprehensive preclinical studies are all within the scope of the journal.

Scope (new version):

Scope (old version):

Biomedicines publishes high-quality papers that address the challenges in bringing biological agents or novel targeted strategies through identification, development, and, ultimately, to clinical use. Therefore, laboratory medicine research, translation medical research, comprehensive preclinical studies, and most clinical studies focused on development and early phase clinical trials are all within the scope of the journal. Some topics include the following:

• Pathogenesis and mechanisms of diseases;
• Cardiovascular diseases;
• Biomaterial in biomedical research;
• Novel targets in various therapeutic areas: cardiovascular, vascular, hematology, oncology, neurology, orthopedics, dermatology, ophthalmology;
• Biomarker discovery and early diagnosis research;
• Drug discovery and development, pharmacotherapy;
• Basic and clinical pharmacology;
• Biopharmaceutical biomedicine: biologics and biosimilars;
• Nanobiotechnological advances in biomedicine: nanomedicine, nanoscaffold implants (synthetic vascular graft), biosensors, bioimaging, gene therapy, vaccine, cell therapy, and tissue engineering;
• Neurobiology and clinical neuroscience;
• Neuromodulation.

• Pathogenesis and mechanisms of diseases
• Translational medical research
• Biomaterial in biomedical research
• Novel targets in various therapeutic areas: cardiovascular, vascular, hematology, oncology, neurology, orthopedics, dermatology, ophthalmology
• Biomarker discovery and early diagnosis research
• Drug discovery and drug development, biomedicine, and pharmacotherapy
• Biopharmaceutical biomedicine: biologics, and biosimilars
• Nanobiotechnological advances in biomedicine: nanomedicine, nanoscaffold implants (synthetic vascular graft), biosensors, bioimaging, gene therapy, vaccine, cell therapy, and tissue engineering.